Schrödinger (SDGR) Files Form 4: Ginsberg Receives New Equity Grants
Rhea-AI Filing Summary
On 18 June 2025, Schrödinger, Inc. (SDGR) filed a Form 4 reporting routine director compensation for board member Gary L. Ginsberg. The award package comprises:
- 5,997 restricted stock units (RSUs) granted at no cost; each RSU converts into one common share when settled.
- Stock options for 9,341 shares with a $21.05 exercise price.
Both the RSUs and the options vest on the earlier of (i) the 12-month anniversary of the 18 Jun 2025 grant date or (ii) the next annual shareholder meeting, subject to Ginsberg’s continued board service. Settlement of vested RSUs is deferred until the earlier of (a) 30 days after separation from service or (b) specific change-in-control events.
Following the grant, Ginsberg’s direct beneficial ownership rises to 17,247 common shares (including the newly issued 5,997 unvested RSUs) plus the newly granted option rights. No shares were sold or disposed of, and all transactions were executed at $0 cash cost to the company or insider.
The filing, signed 20 Jun 2025, reflects normal annual director equity awards under the company’s 2022 Equity Incentive Plan and is not expected to have a material impact on Schrödinger’s capital structure or near-term financials.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine director grant; aligns incentives, immaterial to valuation, neutral market impact.
The Form 4 shows a standard annual equity package for director Gary Ginsberg. The combined 5,997 RSUs and 9,341 options represent a very small fraction of SDGR’s ~74 million outstanding shares and carry no immediate cash cost. Because vesting requires continued service, the grant modestly reinforces board alignment with shareholders. However, the dilution effect is de minimis and the transaction conveys no new information on operations, earnings, or strategy. As such, I view the filing as neutral for valuation and stock price.
TL;DR: Governance-standard equity award; supports alignment, no red flags detected.
This disclosure reflects best-practice governance: annual equity awards awarded under a shareholder-approved 2022 plan, clear vesting terms, and deferred RSU settlement to avoid short-termism. No 10b5-1 trading plan is involved, and the grant size is consistent with peer norms. I do not see any governance concerns or indications of insider sentiment shifts. Overall impact on investors is neutral.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 9,341 | $0.00 | -- |
| Grant/Award | Common Stock | 5,997 | $0.00 | -- |
Footnotes (1)
- Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on June 18, 2025 and shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service. The settlement of such RSUs will be deferred until the earlier of (i) the 30th day following the reporting person's separation from service from the Issuer or (ii) certain change in control events. Includes 5,997 unvested RSUs. The option was granted on June 18, 2025 under the Issuer's 2022 Equity Incentive Plan, as amended. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.
FAQ
What equity awards did SDGR grant to director Gary Ginsberg on 18 June 2025?
At what price are the new SDGR options exercisable?
When do the RSUs and options granted to Gary Ginsberg vest?